Market Performance of Chinese Listed Health Care Companies in 2015-中商产业研究院

内容概括

INTRODUCTION

Health care industry has developeddramatically for the last decades, which faced the threats and opportunities atthe same time. As the increasing quality of civil life conditions andwidespread notion of health care, there are huge motivations for this field.

The health care industry obtainedRMB42.38 billion in 2015 with a YOY rate of 23.96%.

Health care industry is the coresupporting industry of the nation sinceChinabecame an aging society.Meanwhile, the policy of "second child", the reforms of healthinsurance and medicine and plan of Healthy China indicates that health careindustry has extensive market prospects. The expenditure of health care will beincreased stably in recent years, which will reach RMB883.68 billion in 2021.

1) TheAim of this report

n To provide readers with comprehensive & in-depthunderstanding ofChina’shealth care industry;

n To understand the development situation of health careindustry inChina;

n Get more information of the major health care producersinChina;

n Gain insight into the major health care producers aboutoperation;

n To predict what future ofChinahealth care industry will be;

n To reveal opportunities inChinahealth care industry.

2) Benefitfrom the report

n Financial performance in 2015 and YoY changes, includingrevenue, operating profit, net profit, revenue and gross profit margin fromhealth care business;

n Changes of revenue and net profit in the latest five yearsand the reasons;

n Adjustment to business structure in the recent 2-3 years;

n Development strategy anddevelopment trends in the near future.

3) Deliverables

PDF-format report, with around 30-50 pages.

4) Timeneeded

Threeworking days needed.

报告目录

Part	Contents
1	Executive summary
2	Ranking of main listed domestic health care enterprises in 2015
2.1	List ofChina’s listed health care enterprises
2.2	By revenue
2.3	By net profit
2.4	By total assets
2.5	By revenue and gross profit margin of health care business
2.6	By operating profit
2.7	By primary earnings per share
3	Analysis of listed health care enterprises
3.1	Beijing Homyear Capital Holdings Co., Ltd.
3.2	Shinva Medical Instrument Co., Ltd.
3.3	Xi'an International Medical Investment Company Limited
3.4	Aier Eye Hospital Group Co., Ltd.
3.5	Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.
3.6	Zhejiang Dian Diagnostics Co., Ltd.
3.7	Xiamen Comfort Science and Technology Group Co., Ltd.
3.8	Blue Sail Medical Co.,Ltd.
3.9	Meinian Onehealth Healthcare Holdings Co., Ltd.
3.10	Yihua Healthcare Co. Ltd.
3.11	Zhuhai Hokai Medical Instruments Co., Ltd.
3.12	Sinocare Inc.
3.13	Topchoice Medical Investment Co., Inc.
3.14	Shanghai Conant Optics Co., Ltd.
3.15	Edan Instruments, Inc.
3.16	Dirui Industrial Co., Ltd.
3.17	Guangdong Biolight Meditech Co., Ltd.
3.18	China Resources Wandong Medical Equipment Co., Ltd
3.19	Andon Health Co., Ltd.
3.20	Shanghai Kinetic Medical Co., Ltd.
3.21	Guangzhou Improve Medical Instruments Co., Ltd.
3.22	Zhejiang Chimin Pharmaceutical Co., Ltd.
3.23	Guangzhou Wondfo Biotech Co., Ltd.
3.24	Well Lead Medical Co., Ltd.
3.25	Shanghai Jiaoda Onlly Co., Ltd.
3.26	Jiang Xi Sanxin Medtec Co., Ltd.
3.27	Ningbo David Medical Device Co., Ltd
3.28	Winsan (Shanghai) Medical Science and Technology Co., Ltd.

版权声明

本报告所有内容受法律保护，中华人民共和国涉外调查许可证：国统涉外证字第1454号。本报告由中商产业研究院出品，报告版权归中商产业研究院所有。本报告是中商产业研究院的研究与统计成果，报告为有偿提供给购买报告的客户内部使用。未获得中商产业研究院书面授权，任何网站或媒体不得转载或引用，否则中商产业研究院有权依法追究其法律责任。如需订阅研究报告，请直接联系本网站，以便获得全程优质完善服务。本报告目录与内容系中商产业研究院原创，未经本公司事先书面许可，拒绝任何方式复制、转载。在此，我们诚意向您推荐鉴别咨询公司实力的主要方法。